UNSPSC 51461543: Veratrum

This classification denotes a natural product which US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifiers 7DEL4FSK0E, 74V0KIG3TK, VB66Y1LB7K, and 197B3Q7T5Q, the soirce of which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 42756 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Lilianae, Order Liliales, Family Melanthiaceae, Genus Veratrum L., known commonly as VERATRUM.

UNSPSC 51461543 Veratrum, a Commodity code, represents pharmaceutical supply contracts where state and local governments procure generic multi-source drugs and over-the-counter products through cooperative purchasing vehicles and direct wholesaler distribution. State and local buyers under this code include state departments of administration, multistate cooperative purchasing alliances administering shared procurement on behalf of member states and their subdivisions, and participating state and local government health and human services facilities. The scope of work spans the supply of pharmaceuticals with specified National Drug Codes, SKUs, UPCs, and packaging configurations; FDA compliance and current Good Manufacturing Practices certification; Drug Supply Chain Security Act compliance; and pricing delivered through authorized pharmaceutical wholesalers with chargeback systems and electronic data interchange capability. Vendors must maintain contractual relationships with designated wholesaler networks, carry comprehensive insurance (commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000), and meet performance standards with penalties ranging from $200 to $1,500 per violation for late reporting or missed onboarding timelines.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the most recent activity under this code. MMCAP issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon. The procurement requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing, 5 percent each on EDI capability and administrative fee compliance, and 5 percent on administrative data format compliance. Awarded vendors become effective July 1, 2026, under a two-year initial contract term with optional extensions at MMCAP's discretion, and must pay a 3 percent administrative fee on all contract purchases.